J Immunother Cancer
Dr. Lilit Karapetyan, MD
- Medicare services, 2024
- 164
- Medicare patients, 2024
- 97
- Part D claims, 2024
- 99
- Publications
- 38
- MIPS score, 2024
- 88
- Practice address
- 12902 Magnolia Dr, Tampa, FL 33612
- Professional email
- Get professional email
- Personal email
- Get personal email
- Mobile number
- Get mobile number
Primary practice
Find Dr. Karapetyan's professional email, personal email and mobile number
Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.
Dr. Lilit Karapetyan is a hematologist and oncologist in Tampa, Florida
Dr. Karapetyan practices at Moffitt Cancer Hospital in Tampa, Florida, part of Moffitt Cancer Center.
Dr. Karapetyan's NPI, 1174973135, was assigned on June 20, 2016. Dr. Karapetyan graduated from College of Human Medicine - Grand Rapids in 2019. Dr. Karapetyan holds Florida license ME156866.
- NPI
- 1174973135NPI Registry (opens in a new tab)
- Medicare PAC ID
- 8729311980
- NPI enumeration date
- June 20, 2016
- NPI status
- Active
- Accepts Medicare assignment
- Yes
- Offers telehealth
- Yes
- Professional email
- Get email
- Personal email
- Get email
- Mobile number
- Get number
- Sex
- Female
- Estimated age
- 41
- Medical school graduation
- 2019
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Affiliation Data; and Doctors and Clinicians National Downloadable File (CMS)
Dr. Lilit Karapetyan practices at 2 locations in Tampa, Florida
Dr. Karapetyan's primary practice is Moffitt Cancer Hospital, at 12902 Magnolia Dr, Tampa, FL 33612. Dr. Karapetyan also practices at H. Lee Moffitt Cancer Center and Research Institute Hospital, Inc., 10920 McKinley Dr, Tampa, FL 33612.
- Moffitt Cancer HospitalPrimary12902 Magnolia Dr, Tampa, FL 33612
- H. Lee Moffitt Cancer Center and Research Institute Hospital, Inc.10920 McKinley Dr, Tampa, FL 33612 · Hillsborough CountyPhone(813) 745-4673
Sources: NPPES NPI Registry (CMS); Dmand AI Affiliation Data; and Dmand AI Practice Data
Dr. Lilit Karapetyan is affiliated with 4 sites of care and 1 medical group
Dr. Karapetyan's primary practice is Moffitt Cancer Hospital in Tampa, Florida, part of Moffitt Cancer Center. The medical group on file is Moffitt Cancer Center. Dmand AI also links Dr. Karapetyan to 1 more breast imaging center, 1 group practice or clinic and 1 hospital outpatient department, each named with a free account.
Sources: Dmand AI Affiliation Data; and Dmand AI Org Hierarchy Data
Dmand AI tracks the EHR system at Dr. Lilit Karapetyan's practice
Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Karapetyan practices, 4 sites in all. Vendor and product names are available with a free account.
| Site | EHR vendor and product |
|---|---|
| Moffitt Cancer Hospital | Available with a free account |
| +3 more affiliated sites | Available with a free account |
Source: Dmand AI Technology Install Data
For health IT teams
Dmand AI maps EHR vendors, IT decision makers and buying committees across Moffitt Cancer Center and 6.2K+ hospitals, with verified contacts in the same login.
Dr. Lilit Karapetyan is one of 693 hematologists and oncologists in Florida
Hematology and oncology is Dr. Karapetyan's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Karapetyan is board certified in internal medicine by the American Board of Internal Medicine. Dmand AI has Dr. Karapetyan's licenses on file in 4 states: Florida, Ohio, Pennsylvania and Michigan.
Specialties and state licenses
- Hematology and oncology, FloridaPrimary
- Ohio license
- Pennsylvania license
- Internal medicine, Michigan
Clinical focus
Dmand AI lists lymphoma among the conditions Dr. Karapetyan treats.
Hematologists and oncologists near Dr. Karapetyan
Counts of hematologists and oncologists with a Dmand AI profile, by place and practice. Each opens the list.
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks
Dr. Lilit Karapetyan billed Medicare for 164 services in 2024
CMS data shows 164 Medicare services from Dr. Karapetyan across 3 procedure codes in 2024, all of them office visits, for 97 Medicare patients. Medicare paid $19,027 for them. Every service was in a facility, such as a hospital, rather than an office.
Dr. Karapetyan's Medicare services by type, 2023 to 2024
- 2023
- 2024
- Office and hospital visits
- 2023: 1512024: 1649%
Dr. Karapetyan compared with the Florida median for hematologists and oncologists, 2024
- Dr. Karapetyan
- Florida median
- Medicare services
- 164vs 69776% below
- Medicare patients
- 97vs 21856% below
- Part D claims
- 13vs 34196% below
Medians across 638 hematologists and oncologists in Florida with Dmand AI profiles that report each measure.
Dr. Karapetyan's most billed Medicare procedure codes, 2024
CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.
Need commercial claims for Dr. Karapetyan?
Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Karapetyan and other hematologists and oncologists in Florida.
Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks
Dr. Lilit Karapetyan treated 97 Medicare patients in 2024, average age 75
CMS counts 97 Medicare patients who saw Dr. Karapetyan in 2024. The largest group is 65 to 74, with 42 patients. 75% of them have high blood pressure, and 75% have high cholesterol. Their average risk score is 2.35, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.
Across all payers, Dmand AI patient panel data puts Dr. Karapetyan's median patient age at 70, with 38% women.
Dr. Karapetyan's Medicare patients by age, 2024
CMS leaves out age groups with fewer than 11 patients.
Dr. Karapetyan's Medicare patients by sex, 2024
- Women3637%
- Men6163%
Chronic conditions among Dr. Karapetyan's Medicare patients, 2024
- High blood pressure75%
- High cholesterol75%
- Arthritis45%
- Ischemic heart disease42%
- Chronic kidney disease33%
- Anxiety31%
- Cancer27%
- Diabetes26%
Share of Medicare patients with each condition. A patient can have several.
Dr. Karapetyan's patients across all payers
Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.
Patient panel by age, all payers
Median age 70
Patient panel by sex, all payers
- Women38%
- Men62%
Sources: Dmand AI Patient Panel Data; and Medicare Physician & Other Practitioners - by Provider (CMS), 2024 data
Dr. Lilit Karapetyan wrote 99 Medicare Part D claims in 2024
In 2024, Dr. Karapetyan wrote 99 Medicare Part D claims for 39 patients. 82% of them were for generic drugs. CMS names the drug for 13 of them, across 1 drug with 11 or more claims each, at $165 in total drug cost. In 2018, CMS named 12 claims across 1 drug.
Dr. Karapetyan's Part D claims by kind of drug, 2024
- Generic81 claims82%
- Brand-name18 claims18%
Dr. Karapetyan's most prescribed drugs by claims, 2019
CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.
Part D claims for drugs CMS names, 2018 to 2019
- 2018
- 2019
- Claims for drugs CMS names
- 2018: 122019: 138%
Drugs named by CMS: 1 in 2019, 1 in 2018.
Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data
Dr. Lilit Karapetyan scored 88 out of 100 in Medicare's MIPS program for 2024
CMS publishes a Merit-based Incentive Payment System (MIPS) score of 88 out of 100 for Dr. Karapetyan for performance year 2024, reported as part of a group. Dr. Karapetyan accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Karapetyan as offering telehealth.
- Accepts Medicare assignment
- Yes
- Offers telehealth
- Yes
Dr. Karapetyan's MIPS scores, performance year 2024
- 88of 100Final score
- 74of 100Quality
- 100of 100Promoting Interoperability
- 40of 100Improvement Activities
- 71of 100Cost
Each score is out of 100. The final score weighs the categories CMS scored for this clinician.
Sources: Doctors and Clinicians National Downloadable File (CMS); and Clinician Public Reporting: Overall MIPS Performance (CMS), 2024 data, released September 10, 2026
For MedTech and pharma teams
Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.
Dr. Lilit Karapetyan has 38 publications on record
Dmand AI links 38 papers to Dr. Karapetyan, published from 2016 to 2024. 2024 was the busiest year, with 6. The most frequent topics are Melanoma, Skin Neoplasms and Immunotherapy. Dr. Karapetyan has published most often in J Immunother Cancer. Dr. Karapetyan's most frequent co-authors are Jason J. Luke, MD, Andrew David Knight, MD and Heather S. Laird-Fick, MD.
Dr. Karapetyan's papers by year, 2016 to 2024
Topics Dr. Karapetyan writes about most
- Melanoma
- Skin Neoplasms
- Immunotherapy
- Immune Checkpoint Inhibitors
- Antineoplastic Agents
- Carcinoma, Squamous Cell
- Melanoma, Cutaneous Malignant
- Neoplasm Metastasis
Dr. Karapetyan's most frequent co-authors
- Jason J. Luke, MD6 shared papers
- Andrew David Knight, MD5 shared papers
- Heather S. Laird-Fick, MD4 shared papers
Recent publications by Dr. Karapetyan
J Immunother Cancer
See who Dr. Karapetyan researches with
Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Karapetyan works with, so you can find a warm path to the right hematologists and oncologists.
Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage
Dr. Lilit Karapetyan received $257 in industry payments from 2018 to 2023
CMS Open Payments shows 3 general payments to Dr. Karapetyan from 3 drug and device companies from 2018 to 2023. Food and beverage make up the largest share, 61% of the total. Sun Pharmaceutical Industries Inc. paid the most, $146.
General payments to Dr. Karapetyan by program year, 2018 to 2023
General payments to Dr. Karapetyan by kind, 2018 to 2023
- Food and beverage$15761%
- Education$10039%
Companies that paid Dr. Karapetyan the most, 2018 to 2023
Share is of all general payments to this clinician.
Source: Open Payments (CMS), 2025 data, released July 7, 2026
Dr. Lilit Karapetyan graduated from College of Human Medicine - Grand Rapids
Dr. Karapetyan graduated from College of Human Medicine - Grand Rapids in 2019.
- Medical school
- Board certified in internal medicine
- Board certified in medical oncology
Source: Dmand AI Professional Profile Data
Dr. Lilit Karapetyan accepts plans from 5 insurance carriers
Dr. Karapetyan is in network with 5 carriers, including United Healthcare, Blue Cross Blue Shield of Michigan and Humana. HMO plans come from the most carriers, 3. Check the plan with the practice before a visit.
- United Healthcare
- Blue Cross Blue Shield of Michigan
- Humana
- Blue Cross and Blue Shield of Kansas City
- CMS Medicare
Plan types Dr. Karapetyan accepts, by number of carriers
- HMO3
- Medicare3
- PPO3
- POS2
- EPO1
Source: Dmand AI Insurance Network Data
Sources for Dr. Lilit Karapetyan's profile data
| Data on this page | Source |
|---|---|
| NPI, name, sex, specialty and licenses | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data |
| Practice locations and phone | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Affiliation DataDmand AI Practice Data |
| Primary practice, affiliations and health system | Dmand AI Affiliation DataDmand AI Org Hierarchy Data |
| Medicare services and procedure codes | Medicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab) |
| State medians for the same specialty | Dmand AI Peer Benchmarks |
| Medicare patients and the all-payer patient panel | Dmand AI Patient Panel DataMedicare Physician & Other Practitioners - by Provider (CMS) (opens in a new tab) |
| Part D prescribing | Medicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab) |
| MIPS scores, telehealth, assignment and procedure percentiles | Doctors and Clinicians National Downloadable File (CMS) (opens in a new tab)Clinician Public Reporting: Overall MIPS Performance (CMS) (opens in a new tab) |
| Publications, topics and co-authors | PubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage |
| Industry payments | Open Payments (CMS) (opens in a new tab) |
| Training, board certification and memberships | Dmand AI Professional Profile Data |
| Insurance carriers and plan types | Dmand AI Insurance Network Data |
| EHR at each practice site | Dmand AI Technology Install Data |
| Similar physicians | Dmand AI Affiliation Data |
Data last refreshed October 2026Report an inaccuracyRemove my information
FAQ
Frequently asked questions about Dr. Lilit Karapetyan
Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.
What is Dr. Lilit Karapetyan's NPI number?
Dr. Lilit Karapetyan's NPI number is 1174973135. It was assigned on June 20, 2016, and it is active in the NPI Registry.
What kind of doctor is Dr. Lilit Karapetyan?
Dr. Lilit Karapetyan is a hematologist and oncologist in Tampa, Florida. The primary specialty in the NPI Registry is Hematology & Oncology Physician (taxonomy code 207RH0003X).
Where does Dr. Lilit Karapetyan practice?
Dr. Karapetyan practices at 12902 Magnolia Dr, Tampa, FL 33612. Dr. Karapetyan also practices at 10920 McKinley Dr, Tampa, FL 33612. Dr. Karapetyan's primary practice is Moffitt Cancer Hospital in Tampa, Florida, part of Moffitt Cancer Center. Dmand AI also links Dr. Karapetyan to 1 breast imaging center, 1 group practice or clinic and 1 hospital outpatient department.
What is Dr. Lilit Karapetyan's medical license number?
Dr. Karapetyan holds Florida license ME156866, one of the licenses on file in 4 states.
Which states has Dr. Lilit Karapetyan been licensed in?
Dmand AI has state licenses on file for Dr. Karapetyan in Florida (2022 to 2026), Ohio (since 2018), Pennsylvania (2019 to 2022) and Michigan (2016 to 2019).
Which hospitals is Dr. Lilit Karapetyan affiliated with?
Dr. Karapetyan practices at Moffitt Cancer Hospital in Tampa, Florida.
What medical group is Dr. Lilit Karapetyan part of?
Dr. Karapetyan is linked to Moffitt Cancer Center.
Does Dr. Lilit Karapetyan accept Medicare?
Yes. CMS data shows Dr. Karapetyan billed Medicare for 164 services in 2024, and Dr. Karapetyan accepts Medicare assignment.
Does Dr. Lilit Karapetyan offer telehealth?
Yes. The CMS Doctors and Clinicians file lists Dr. Karapetyan as offering telehealth services.
What is Dr. Lilit Karapetyan's MIPS score?
Dr. Karapetyan's MIPS final score for performance year 2024 is 88 out of 100, reported as part of a group.
Show 10 more questionsShow fewer questions
How many Medicare patients does Dr. Lilit Karapetyan see?
CMS counts 97 Medicare patients who saw Dr. Karapetyan in 2024, with an average age of 75.
Is Dr. Lilit Karapetyan board certified?
Yes. Dr. Karapetyan is board certified in internal medicine by the American Board of Internal Medicine.
What services does Dr. Lilit Karapetyan bill to Medicare?
In 2024, Dr. Karapetyan's most billed Medicare services were office visit, established patient (99215), office visit, new patient (99205) and office visit, established patient (99214).
Where did Dr. Lilit Karapetyan go to medical school?
Dr. Karapetyan graduated from College of Human Medicine - Grand Rapids in 2019.
What drugs does Dr. Lilit Karapetyan prescribe most?
In 2019 Medicare Part D data, Dr. Karapetyan's most prescribed drugs by claims were Atorvastatin Calcium.
Has Dr. Lilit Karapetyan received payments from drug or device companies?
CMS Open Payments shows $257 in general payments to Dr. Karapetyan from 3 companies from 2018 to 2023. The largest total came from Sun Pharmaceutical Industries Inc.
How long has Dr. Lilit Karapetyan been practicing?
Dr. Karapetyan graduated from medical school in 2019, 7 years ago.
Does Dr. Lilit Karapetyan do research?
Dmand AI links 38 publications to Dr. Karapetyan, published from 2016 to 2024.
Who does Dr. Lilit Karapetyan publish with?
Dr. Karapetyan's most frequent co-authors are Jason J. Luke, MD (6 shared papers), Andrew David Knight, MD (5 shared papers) and Heather S. Laird-Fick, MD (4 shared papers).
What insurance does Dr. Lilit Karapetyan accept?
Dr. Karapetyan is in network with 5 carriers, including United Healthcare, Blue Cross Blue Shield of Michigan and Humana. HMO plans come from the most carriers, 3. Check the plan with the practice before a visit.
Selling to hematology and oncology practices?
See hematologists and oncologists in Florida by site of care and group
Find the practices, groups and hospitals they work with, and the right people to contact at each.
- 30 days free
- Self-serve
- No credit card